Press Release

HINGHAM, Mass. , Oct. 07, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for patent application No. 15/592,227, which pertains to a device for reducing dialysis shunt stenosis.

Webinar to be Held on Wednesday August 26th at 11am ET HINGHAM, Mass. , Aug. 20, 2020 (GLOBE NEWSWIRE) -- Following its participation at the Needham Virtual Med Tech & Diagnostic conference, as well as the overwhelming interest generated since its recent announcement which included the outcome of a

World’s First Fully Disposable Surgical Robot Achieved all Endpoints with No Intraoperative Adverse Events LIBERTY™ Robotic System being remotely operated LIBERTY™ Robotic System Remotely Performed Procedures have the Potential to Reduce Radiation Exposure, Physical Strain and Cross Contamination

Results to be shared on August 17th during Needham’s Virtual Med Tech & Diagnostics Conference HINGHAM, Mass. , Aug. 13, 2020 (GLOBE NEWSWIRE) -- At the upcoming Needham Virtual Med Tech & Diagnostics Conference , being held on Monday, August 17, 2020 , Microbot Medical Inc.

Vascular Interventions Executive Will Contribute Significantly to the Development and Commercialization of LIBERTY Robotic System HINGHAM, Mass. , Aug. 03, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has further strengthened the Company’s capabilities and expertise as Mr.

Proven Track Record of Numerous M&A and Strategic Collaboration Transactions HINGHAM, Mass. , April 01, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced the appointment of Aileen Stockburger to the Company's Board of Directors, effective April 1, 2020 . Ms.

HINGHAM, Mass. , March 03, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Microbot Medical Inc.  (NASDAQ: MBOT), please note that in the first paragraph the appointment of Eyal Morag, M.D. has been changed to commencing June 2020 and in the fourth paragraph

HINGHAM, Mass. , March 03, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (NASDAQ: MBOT), announced the appointment of Eyal Morag , M.D., a leading radiologist, to Chief Medical Officer, effective immediately. In his new role, Dr. Morag will lead the development and execution of the clinical

HINGHAM, Mass., Jan. 08, 2020 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has received an official communication from the European Patent Office (EPO) regarding its intention to grant European Patent Application No. 11795301, covering the Company’s Self-Cleaning Shunt (SCS™).